Home › Funds › Point72 Asset Management › MBX
Point72 Asset Management position in MBX
MBX BIOSCIENCES INC · Health Care
Latest position (Q4 2025)680.61K sh
Reported value held$21.47M
Portfolio Weight0.03%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 15.60K | $405.29K | New |
| Q1 2025 | 110.48K | $815.36K | New |
| Q1 2025 | 110.48K | $815.36K | New |
| Q2 2025 | 973.79K | $11.11M | Add |
| Q2 2025 | 973.79K | $11.11M | Add |
| Q3 2025 | 627.67K | $10.98M | Reduce |
| Q4 2025 | 680.61K | $21.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MBX
- Fidelity Management & Research (FMR) 5.32M sh · $293.82M · Q2 2026
- Wellington Management Group 4.98M sh · $274.76M · Q2 2026
- BlackRock Inc 3.32M sh · $183.47M · Q2 2026
- Vanguard Group 1.82M sh · $57.33M · Q4 2025
- Geode Capital Management 773.07K sh · $42.68M · Q2 2026
- Goldman Sachs Group 459.00K sh · $25.34M · Q2 2026
- Marshall Wace 401.88K sh · $22.18M · Q2 2026
- Bank of America Corp 298.93K sh · $16.50M · Q2 2026
- UBS Group AG 272.75K sh · $15.06M · Q2 2026
- Franklin Resources 252.66K sh · $13.95M · Q2 2026
- Morgan Stanley 248.56K sh · $13.72M · Q2 2026
- Northern Trust Corp 246.68K sh · $13.62M · Q2 2026